Página inicialPodcasts FDA Drug Safety PodcastsFDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopauseFDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause20 de setembro de 2024FDA Drug Safety PodcastsPlayOuvir episódio
